Press

AI, machine learning offer hope for speeding Alzheimer’s development

Brian Orelli for BioWorld

Machine learning and artificial intelligence (AI) are already being actively used in drug discovery to evaluate potential binding of small-molecule drugs to proteins, but there's potential for the technologies to be used on the development side as well, especially in hard-to-treat diseases such as Alzheimer's disease.